James McCaslin

Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

Antithrombotic Therapy for VTE Disease

Antithrombotic Therapy for VTE Disease

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension

Home versus in-patient treatment for deep vein thrombosis

Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism

Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis